Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Francesco Alessandri and Giancarlo Ceccarelli.
Connection Strength

1.926
  1. The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study). J Med Virol. 2021 Jul; 93(7):4319-4325.
    View in: PubMed
    Score: 0.234
  2. Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study. Front Nutr. 2020; 7:613928.
    View in: PubMed
    Score: 0.231
  3. Acute Kidney Injury and COVID-19: A Picture from an Intensive Care Unit. Blood Purif. 2021; 50(6):767-771.
    View in: PubMed
    Score: 0.231
  4. Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. Eur J Clin Invest. 2021 Jan; 51(1):e13418.
    View in: PubMed
    Score: 0.227
  5. Is teicoplanin a complementary treatment option for COVID-19? The question remains. Int J Antimicrob Agents. 2020 Aug; 56(2):106029.
    View in: PubMed
    Score: 0.221
  6. Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality. Intern Emerg Med. 2021 08; 16(5):1231-1237.
    View in: PubMed
    Score: 0.060
  7. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection. 2022 Feb; 50(1):83-92.
    View in: PubMed
    Score: 0.060
  8. Post-traumatic Stress Disorder Among COVID-19 Survivors at 3-Month Follow-up After Hospital Discharge. J Gen Intern Med. 2021 06; 36(6):1702-1707.
    View in: PubMed
    Score: 0.059
  9. Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review. Int J Environ Res Public Health. 2021 01 12; 18(2).
    View in: PubMed
    Score: 0.058
  10. Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox? J Thromb Thrombolysis. 2021 Jul; 52(1):105-110.
    View in: PubMed
    Score: 0.058
  11. Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report. Thromb Haemost. 2021 01; 121(1):102-105.
    View in: PubMed
    Score: 0.058
  12. Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of probiozovid trial. J Med Virol. 2021 04; 93(4):2210-2220.
    View in: PubMed
    Score: 0.057
  13. Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19. Br J Haematol. 2020 08; 190(4):e214-e218.
    View in: PubMed
    Score: 0.056
  14. Nox2 activation in Covid-19. Redox Biol. 2020 09; 36:101655.
    View in: PubMed
    Score: 0.056
  15. Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19. Front Med (Lausanne). 2020; 7:389.
    View in: PubMed
    Score: 0.056
  16. Is Albumin Predictor of Mortality in COVID-19? Antioxid Redox Signal. 2021 07 10; 35(2):139-142.
    View in: PubMed
    Score: 0.056
  17. Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19. Circ Res. 2020 07 17; 127(3):400-401.
    View in: PubMed
    Score: 0.055
  18. Specific dynamic of serum procalcitonin in critically ill patients affected by Gram-negative bacilli septic thrombophlebitis. Crit Care. 2018 07 23; 22(1):178.
    View in: PubMed
    Score: 0.049
  19. Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients. Antimicrob Agents Chemother. 2018 06; 62(6).
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.